Ken Griffin Singular Genomics Systems, Inc. Call Options Transaction History

Citadel Advisors LLC

  • $509 Billion
  • Q1 2024

Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.4 - $0.61 $4,800 - $7,320
12,000 Added 1000.0%
13,200 $6,000
Q4 2023

Feb 14, 2024
SELL
$0.33 - $0.58 $2,310 - $4,059
-7,000 Reduced 85.37%
1,200 $0
Q3 2023

Nov 14, 2023
SELL
$0.37 - $0.99 $1,591 - $4,257
-4,300 Reduced 34.4%
8,200 $3,000
Q2 2023

Aug 14, 2023
BUY
$0.78 - $1.28 $546 - $896
700 Added 5.93%
12,500 $10,000
Q1 2023

May 15, 2023
BUY
$1.1 - $2.95 $7,370 - $19,765
6,700 Added 131.37%
11,800 $14,000
Q4 2022

Feb 14, 2023
BUY
$1.82 - $2.71 $9,282 - $13,821
5,100 New
5,100 $10,000

Others Institutions Holding OMIC

# of Institutions
44
Shares Held
24.7M
Call Options Held
13.2K
Put Options Held
0
View Full List

About Singular Genomics Systems, Inc.

OMIC Quotes by TradingView
  • Ticker OMIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 71,193,296
  • Market Cap $582M
  • Description
  • Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...
More about OMIC
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email